🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Etanercept, a biological antipsoriatic drug with anti-tumor-necrosis factor...
Status
Completed
Location
Medical University of Graz, Department of Dermatology
Start Date
2006-08
Trial ID
NCT00550030
Treatments Being Tested
This study evaluates whether exosomes derived from human umbilical cord mes...
Status
Not Yet Recruiting
Location
Xijing Hospital, The First Affiliated Hospital of Air Force Medical University
Start Date
2026-04
Trial ID
NCT07519031
Ustekinumab, an IL-12/23 antibody has been approved in the E.C. and U.S.A. ...
Status
Completed
Location
Medical University, Department of Dermatology
Start Date
2009-03
Trial ID
NCT00870285
Treatments Being Tested
Assess the efficacy and safety of alefacept with nbUVB compared to alefacep...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00658606
Treatments Being Tested
An open label, single arm study to evaluate the study and efficacy of efali...
Status
Completed
Location
Derm Research, PLLC
Start Date
2006-03
Trial ID
NCT00302445
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Ruxolit...
Status
Completed
Location
First Oc Dermatology
Start Date
2022-05-05
Trial ID
NCT05247489
Treatments Being Tested
This research will explore the potential effects of Narrow-Band Ultra Viole...
Status
Completed
Location
BC Childrens Hospital
Start Date
2018-02-19
Trial ID
NCT03962673
Treatments Being Tested
vitiligo is an autoimmune depigmenting skin disorder characterized by milky...
Status
Recruiting
Location
Qena university hospital, Qena faculty of medicine
Start Date
2024-10-02
Trial ID
NCT06768840
Treatments Being Tested
This is a Phase 2b, randomized, double blind, parallel group, multicenter s...
Status
Completed
Location
Marvel Research, LLC
Start Date
2018-11-26
Trial ID
NCT03715829
This is a single-center, open-label, pilot study. A total of 30 subjects (1...
Status
Completed
Location
UCSF Psoriasis and Skin Treatment Center
Start Date
2008-10
Trial ID
NCT00800982
Treatments Being Tested